179 related articles for article (PubMed ID: 16809994)
1. Naloxone reversal of buprenorphine-induced respiratory depression.
van Dorp E; Yassen A; Sarton E; Romberg R; Olofsen E; Teppema L; Danhof M; Dahan A
Anesthesiology; 2006 Jul; 105(1):51-7. PubMed ID: 16809994
[TBL] [Abstract][Full Text] [Related]
2. Opioid-induced respiratory effects: new data on buprenorphine.
Dahan A
Palliat Med; 2006; 20 Suppl 1():s3-8. PubMed ID: 16764215
[TBL] [Abstract][Full Text] [Related]
3. Mechanism-based pharmacokinetic-pharmacodynamic modelling of the reversal of buprenorphine-induced respiratory depression by naloxone : a study in healthy volunteers.
Yassen A; Olofsen E; van Dorp E; Sarton E; Teppema L; Danhof M; Dahan A
Clin Pharmacokinet; 2007; 46(11):965-80. PubMed ID: 17922561
[TBL] [Abstract][Full Text] [Related]
4. Non-analgesic effects of opioids: opioid-induced respiratory depression.
Boom M; Niesters M; Sarton E; Aarts L; Smith TW; Dahan A
Curr Pharm Des; 2012; 18(37):5994-6004. PubMed ID: 22747535
[TBL] [Abstract][Full Text] [Related]
5. Incidence, Reversal, and Prevention of Opioid-induced Respiratory Depression.
Dahan A; Aarts L; Smith TW
Anesthesiology; 2010 Jan; 112(1):226-38. PubMed ID: 20010421
[TBL] [Abstract][Full Text] [Related]
6. Buprenorphine to reverse respiratory depression from methadone overdose in opioid-dependent patients: a prospective randomized trial.
Zamani N; Buckley NA; Hassanian-Moghaddam H
Crit Care; 2020 Feb; 24(1):44. PubMed ID: 32033582
[TBL] [Abstract][Full Text] [Related]
7. Naloxone reversal of buprenorphine-induced respiratory depression.
Gal TJ
Clin Pharmacol Ther; 1989 Jan; 45(1):66-71. PubMed ID: 2491980
[TBL] [Abstract][Full Text] [Related]
8. Naloxone reversal of morphine- and morphine-6-glucuronide-induced respiratory depression in healthy volunteers: a mechanism-based pharmacokinetic-pharmacodynamic modeling study.
Olofsen E; van Dorp E; Teppema L; Aarts L; Smith TW; Dahan A; Sarton E
Anesthesiology; 2010 Jun; 112(6):1417-27. PubMed ID: 20461002
[TBL] [Abstract][Full Text] [Related]
9. Naloxone reversal of opioid-induced respiratory depression with special emphasis on the partial agonist/antagonist buprenorphine.
Sarton E; Teppema L; Dahan A
Adv Exp Med Biol; 2008; 605():486-91. PubMed ID: 18085322
[TBL] [Abstract][Full Text] [Related]
10. Buprenorphine induces ceiling in respiratory depression but not in analgesia.
Dahan A; Yassen A; Romberg R; Sarton E; Teppema L; Olofsen E; Danhof M
Br J Anaesth; 2006 May; 96(5):627-32. PubMed ID: 16547090
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the respiratory effects of intravenous buprenorphine and fentanyl in humans and rats.
Dahan A; Yassen A; Bijl H; Romberg R; Sarton E; Teppema L; Olofsen E; Danhof M
Br J Anaesth; 2005 Jun; 94(6):825-34. PubMed ID: 15833777
[TBL] [Abstract][Full Text] [Related]
12. Buprenorphine antagonism of ventilatory depression following fentanyl anaesthesia.
Boysen K; Hertel S; Chraemmer-Jørgensen B; Risbo A; Poulsen NJ
Acta Anaesthesiol Scand; 1988 Aug; 32(6):490-2. PubMed ID: 3176837
[TBL] [Abstract][Full Text] [Related]
13. Effect of sustained high buprenorphine plasma concentrations on fentanyl-induced respiratory depression: A placebo-controlled crossover study in healthy volunteers and opioid-tolerant patients.
Moss LM; Algera MH; Dobbins R; Gray F; Strafford S; Heath A; van Velzen M; Heuberger JAAC; Niesters M; Olofsen E; Laffont CM; Dahan A; Groeneveld GJ
PLoS One; 2022; 17(1):e0256752. PubMed ID: 35085249
[TBL] [Abstract][Full Text] [Related]
14. Donepezil reverses buprenorphine-induced central respiratory depression in anesthetized rabbits.
Sakuraba S; Tsujita M; Arisaka H; Takeda J; Yoshida K; Kuwana S
Biol Res; 2009; 42(4):469-75. PubMed ID: 20140302
[TBL] [Abstract][Full Text] [Related]
15. Interaction of mu-opioid receptor agonists and antagonists with the analgesic effect of buprenorphine in mice.
Kögel B; Christoph T; Strassburger W; Friderichs E
Eur J Pain; 2005 Oct; 9(5):599-611. PubMed ID: 16139189
[TBL] [Abstract][Full Text] [Related]
16. Intravenous Buprenorphine: A Substitute for Naloxone in Methadone-Overdosed Patients?
Zamani N; Hassanian-Moghaddam H
Ann Emerg Med; 2017 Jun; 69(6):737-739. PubMed ID: 28237362
[TBL] [Abstract][Full Text] [Related]
17. Reversal and Prevention of the Respiratory-Depressant Effects of Heroin by the Novel
Gerak LR; Maguire DR; Woods JH; Husbands SM; Disney A; France CP
J Pharmacol Exp Ther; 2019 Feb; 368(2):229-236. PubMed ID: 30463875
[TBL] [Abstract][Full Text] [Related]
18. Buprenorphine-related complications in elderly hospitalised patients: a case series.
Richards S; Torre L; Lawther B
Anaesth Intensive Care; 2017 Mar; 45(2):256-261. PubMed ID: 28267949
[TBL] [Abstract][Full Text] [Related]
19. Kinetics of respiratory depression in rats induced by buprenorphine and its metabolite, norbuprenorphine.
Ohtani M; Kotaki H; Nishitateno K; Sawada Y; Iga T
J Pharmacol Exp Ther; 1997 Apr; 281(1):428-33. PubMed ID: 9103526
[TBL] [Abstract][Full Text] [Related]
20. [Development of continuous monitoring of spontaneous respiration in the postoperative phase. 2. Cutaneous oxygen and carbon dioxide partial pressures following i.v. bolus application of fentanyl, buprenorphine, naloxone and amiphenazole in healthy adult subjects].
Lehmann KA; Huttarsch H; Schroeder B; Zech D
Anaesthesist; 1992 Apr; 41(4):192-8. PubMed ID: 1350432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
